Baixar PDF

Outros usuários também visualizaram estes artigos

Follow-up of children with sickle cell anemia screened with transcranial Doppler and enrolled in a primary prevention program of ischemic stroke Alessandra Palhoni Sabarense; Célia Maria Silva; Maristela Braga de Sousa Rodrigues Muniz; Marcos Borato Viana;
Hematol Transfus Cell Ther. 2022;44:478-84
Impact of Imatinib on reducing the painful crisis in patients with sickle cell disease Mojtaba Karimi; Mohammad Bahadoram; Ladan Mafakher; Mohammadhossein Rastegar;
Hematol Transfus Cell Ther. 2024;46:387-92
Consensus of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy (ABHH) and the Brazilian Ministry of Health - General management of blood and blood products on the tests necessary for the release of exceptional medicines for sickle cell disease Clarisse Lobo; Aderson Araújo; Alexandre de Albuquerque Antunes; Ana Cristina Silva Pinto; Ariadne Carvalho Godinho; Cassia Silvestre Mariano Pires; Cinthia Cristina Matheus; Xerez de Albuquerque; Daniele Campos Fontes Neves; Fábio de Lima Moreno; Giorgio Baldanzi; Grazziella Curado Siufi; Heloisa Helena Pereira Miranda; Jane Hankins; Joice Aragão; Josefina Aparecida Pellegrini Braga; Juliana Touguinha Neves Martins; Luciana Campos Costa Machado de Souza; Maria Stella Figueiredo; Mirella Rodrigues Oliveira; Patricia Santos Resende Cardoso; Patricia Costa Alves Pinto; Patricia Gomes Moura; Rodolfo Delfini Cançado; Paulo Ivo Cortez de Araujo; Sara Olalla Saad; Sandra Regina Loggetto; Teresa Cristina Cardoso Fonseca;
Hematol Transfus Cell Ther. 2024;46:67-71